title: Sensory responses of neurons in the medial septal area in conditions of modulation of theta activity using the alpha-2-adrenoreceptor agonist clonidine.
abstract: Our previous studies on conscious rabbits showed that administration of the alpha-2-adrenoreceptor agonist clonidine induces dose-dependent changes in theta oscillations in the septohippocampal system. Low doses of clonidine suppressed theta activity, while high doses produced significant potentiation. It was suggested that the different effects of clonidine might be associated with differences in the sensitivities of pre- and postsynaptic alpha-2-adrenoreceptors to clonidine, this agent being a pure agonist of noradrenaline when used at high doses. It was suggested that functional synergism occurs between the activatory reticular formation and the noradrenergic system of the locus ceruleus in controlling the theta rhythm. The present study was performed to identify the nature of the responses of sensory neurons in the medial septal region in conditions of alterations in the magnitude of the theta rhythm induced by different doses of clonidine. Low and high doses of the agonist given bilaterally into the lateral ventricles were found to have different effects on the sensory responses of neurons in the medial septal region. Injection of small clonidine doses (0.5 microg in 5 microl into each lateral ventricle), which decrease theta activity, was found to lead to weakening of activatory processes and enhancement of inhibitory processes in the medial septal region. The number of activatory responses decreased significantly and persisting responses were significantly weakened; inhibitory responses, conversely, were seen more frequently and were significantly more marked. Administration of high clonidine doses (5 microg in 5 microl), which produce sharp increases in theta oscillations, led to significant reductions in the reactivity of cells in the medial septal region to sensory stimuli (from 76.8% in controls to 45% after clonidine), regardless of the nature of the initial responses. Persisting activatory and inhibitory responses were in most cases less marked than the initial responses. These results suggest that alpha-2-adrenoreceptors are involved in controlling the sensory reactivity of neurons in the medial septal region. The impairment of the normal processing of sensory stimuli seen during the continuous generation of rhythmic activity provoked by injection of large clonidine doses supports the role of the theta rhythm in the septohippocampal system as an active filter during the processing and recording of information.
authors.affiliation: Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences. Kichigina@iteb.ru
authors.forename: V F
authors.initials: VF
authors.lastname: Kichigina
authors.forename: E S
authors.initials: ES
authors.lastname: Kutyreva
authors.forename: V V
authors.initials: VV
authors.lastname: Sudnitsyn
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D003000:Clonidine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D009475:Neurons, Afferent / Q000187:drug effects* / Q000502:physiology; D010812:Physical Stimulation / Q000379:methods; D011817:Rabbits; D020665:Septum of Brain / Q000166:cytology* / Q000187:drug effects; D013826:Theta Rhythm / Q000187:drug effects*
chemical_list: D000316:Adrenergic alpha-Agonists; D003000:Clonidine
references.citation: J Neurosci. 1989 Jun;9(6):2131-40
references.pmid: 2542486
references.citation: Neuroscience. 1990;39(2):431-9
references.pmid: 2087265
references.citation: Neuropharmacology. 1996 Jun;35(6):679-87
references.pmid: 8887976
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(4):419-58
references.pmid: 3321150
references.citation: Eur J Neurosci. 2000 Jan;12(1):264-72
references.pmid: 10651881
references.citation: J Neurophysiol. 1997 Jun;77(6):3326-39
references.pmid: 9212278
references.citation: Neurochem Res. 1997 Aug;22(8):957-66
references.pmid: 9239751
references.citation: Neuroscience. 1984 Nov;13(3):819-25
references.pmid: 6084829
references.citation: Brain Res. 1979 Mar 16;163(2):223-34
references.pmid: 218681
references.citation: Prog Neurobiol. 1995 Apr;45(6):523-83
references.pmid: 7624485
references.citation: Brain Res. 1980 Sep 29;198(1):95-117
references.pmid: 7407597
references.citation: Neuroscience. 1993 Apr;53(4):993-1007
references.pmid: 8506032
references.citation: Neuroscience. 1999;94(3):745-53
references.pmid: 10579565
references.citation: Neuroscience. 1999;94(2):453-63
references.pmid: 10579208
references.citation: Neuroscience. 1998 May;84(2):413-29
references.pmid: 9539213
references.citation: Neural Plast. 2000;7(1-2):133-46
references.pmid: 10709220
references.citation: Neuroscience. 1993 Apr;53(4):981-91
references.pmid: 8506031
references.citation: Brain Res. 1998 Apr 20;790(1-2):33-44
references.pmid: 9593812
references.citation: Exp Brain Res. 1998 Feb;118(3):361-72
references.pmid: 9497143
references.citation: Brain Res. 1993 Jun 18;614(1-2):21-8
references.pmid: 7688646
references.citation: Brain Res. 1982 Dec 16;253(1-2):173-83
references.pmid: 6295549
references.citation: Prog Brain Res. 1991;88:521-32
references.pmid: 1813932
references.citation: Exp Brain Res. 1985;59(3):497-506
references.pmid: 4029326
references.citation: Brain Res. 1975 Mar 21;86(2):229-42
references.pmid: 234774
references.citation: Neuroscience. 1993 Apr;53(4):971-9
references.pmid: 8506030
references.citation: J Comp Neurol. 1998 Jun 8;395(3):310-27
references.pmid: 9596526
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 2002 Mar-Apr;52(2):195-204
references.pmid: 12013656
references.citation: Drugs Aging. 1994 Aug;5(2):116-26
references.pmid: 7981483
references.citation: Neuropharmacology. 1988 Apr;27(4):391-8
references.pmid: 2843779
references.citation: Ann N Y Acad Sci. 1984;430:7-25
references.pmid: 6146285
references.citation: Brain Res. 1993 Jun 18;614(1-2):191-6
references.pmid: 8102313
references.citation: Neuroscience. 1997 Dec;81(4):893-926
references.pmid: 9330355
references.citation: J Comp Neurol. 1988 Sep 22;275(4):511-41
references.pmid: 3192756
references.citation: Commun Psychopharmacol. 1980;4(1):83-90
references.pmid: 7398246
references.citation: Brain Res Bull. 1979 Jul-Aug;4(4):491-5
references.pmid: 314836
references.citation: J Neurophysiol. 1981 Nov;46(5):1140-59
references.pmid: 7299451
references.citation: Neurosci Res. 2001 Jan;39(1):71-7
references.pmid: 11164254
references.citation: Electroencephalogr Clin Neurophysiol. 1965 Jul;19:25-33
references.pmid: 14325384